Skip to main content

Table 1 Correlation between miR-501 expression and EC clinicopathological parameters

From: MiR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancer

Parameters

n

miR-501 level

p value

Low (n = 332)

High (n = 206)

Age

 < 55

97

61

36

0.807

 ≥ 55

437

269

168

Peritoneal washing

 Negative

344

215

129

0.681

 Positive

57

34

23

Tumor status

 With tumor

77

52

25

0.688

 Tumor free

422

275

147

Lymph nodes (pelvic)

 Negative

339

213

126

0.018*

 Positive

73

35

38

Lymph nodes (aortic)

 Negative

263

160

103

0.119

 Positive

36

17

19

Stage

 I

338

202

136

0.200

 II–IV

199

130

69

Recurrence

 No

415

279

136

0.842

 Yes

76

46

30

  1. The data was from TCGA. The follow-up data of some patients are not complete, so the case number of some groups is smaller than the total, but there is no difference between the expression level of miR-501 in the omitted individuals compared with the listed ones
  2. *p < 0.05